Incurin (estriol) Tablets
Price:
SKU:
80167-475-611
Availability:
In Stock
- Incurin® (estriol) Tablets effectively treat female canine urinary incontinence in spayed females
- Contains estriol, a naturally occurring, short-acting estrogen
- One simple starting dose for all female dogs
+
Wishlist
- This product is available by prescription only.
- Due to federal and state laws, we cannot accept returns on prescription items.
Product Details
- Incurin® (estriol) Tablets effectively treat female canine urinary incontinence in spayed females
- Contains estriol, a naturally occurring, short-acting estrogen
- One simple starting dose for all female dogs
Product Expiration Dates
Incurin® (estriol) Tablets effectively treat canine urinary incontinence in spayed females. Contains estriol; a naturally occurring, short-acting estrogen. Estriol can help restore estrogen levels in spayed dogs to support a dog's natural processes for maintaining urethral tone for urinary control. It differs from most other estrogens because it binds with estrogen receptors for a short time minimizing estrogen related side effects.
Studies have shown 93% of dogs treated with Incurin® tablets for dogs were improved or continent by six weeks.
Incurin® for dogs has convenient, once-a-day dosing with one simple starting dose for all female dogs and just one tablet size.
IMPORTANT SAFETY INFORMATION: Evaluation of factors contributing to urinary incontinence should be considered prior to administration of INCURIN® Tablets. Do not use with other estrogens. The concomitant use of INCURIN® Tablets with other estrogens or with glucocorticoids has not been evaluated. The safe use of INCURIN® Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, male dogs, dogs less than 1 year of age, or dogs with liver disease. Reported adverse reactions include anorexia, emesis, polydipsia, and swollen vulva. Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN® Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. For complete safety information, refer to the product label.
Studies have shown 93% of dogs treated with Incurin® tablets for dogs were improved or continent by six weeks.
Incurin® for dogs has convenient, once-a-day dosing with one simple starting dose for all female dogs and just one tablet size.
IMPORTANT SAFETY INFORMATION: Evaluation of factors contributing to urinary incontinence should be considered prior to administration of INCURIN® Tablets. Do not use with other estrogens. The concomitant use of INCURIN® Tablets with other estrogens or with glucocorticoids has not been evaluated. The safe use of INCURIN® Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, male dogs, dogs less than 1 year of age, or dogs with liver disease. Reported adverse reactions include anorexia, emesis, polydipsia, and swollen vulva. Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN® Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. For complete safety information, refer to the product label.
Side Effects:
The most common side effects associated with Incurin® treatment included loss of appetite, vomiting, excessive water drinking and swollen vulva. Other side effects that could occur are: anorexia, emesis, polydipsia, anxiety, sexual attractiveness, somnolence, hypersalivation, estrous behavior, and mammary hyperplasia.
Warnings:
Human Warnings: Women who are of child-bearing age or those who are breastfeeding should use caution when administering Incurin® Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans.
Animal Warnings: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for Incurin® Tablets have shown that estriol-treated dogs are at low risk for developing these conditions.
Precautions:
Do not use with other estrogens. The concomitant use of Incurin® Tablets with glucocorticoids has not been evaluated. The use of Incurin® table in dogs with liver disease has not been evaluated. The safe use of Incurin® Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, male dogs, and dogs less than 1 one year of age.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Keep out of the reach of children
The most common side effects associated with Incurin® treatment included loss of appetite, vomiting, excessive water drinking and swollen vulva. Other side effects that could occur are: anorexia, emesis, polydipsia, anxiety, sexual attractiveness, somnolence, hypersalivation, estrous behavior, and mammary hyperplasia.
Warnings:
Human Warnings: Women who are of child-bearing age or those who are breastfeeding should use caution when administering Incurin® Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans.
Animal Warnings: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for Incurin® Tablets have shown that estriol-treated dogs are at low risk for developing these conditions.
Precautions:
Do not use with other estrogens. The concomitant use of Incurin® Tablets with glucocorticoids has not been evaluated. The use of Incurin® table in dogs with liver disease has not been evaluated. The safe use of Incurin® Tablets has not been evaluated in intact female dogs, pregnant or lactating dogs, male dogs, and dogs less than 1 one year of age.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Keep out of the reach of children
Disposal of Unused Prescription Medications
- Return unwanted or unused medications to Revival Animal Health in person, or visit www.disposemymeds.org to find a pharmacy near you.
- A secondary method of drug disposal is to remove the unwanted medication from any wrappers or containers and place it in a plastic bag with moist coffee grounds or cat litter. This can be disposed of in the regular garbage collection.
- Please do NOT dispose of unwanted meds down the drain or toilet, as this may eventually find its way into the human water supply.
Learn more about disposal of unused prescription medications here.
Disposal of Medical Sharps
- When you're finished with the syringe and needle, do not try to recap, remove, bend or break the needle. This is where most injuries occur.
- Dispose the syringe and needle immediately in a nearby sharps container. All sharps must be deposited in a puncture-proof container. Make sure your storage location is child and animal proof.
- As with all product handling, make sure you wash your hands after handling medical sharps.
Disposal of Sharps Container
- When your sharps container is half-full, sift dry Portland Cement throughout the sharps. Fill the container with water, and rotate until the cement is mixed and the sharps have been distributed throughout the cement mixture. Let cement dry for 24 hours.
- Seal the lid of the container tightly and use duct tape to seal. Label the container "Livestock Sharps" to properly identify the contents.
- Dispose of the containers in accordance with your state's regulations.
Our pharmacy hours are Monday-Friday 8:00 a.m. − 4:30 p.m. CST.
Active ingredient: Estriol
Storage:
Store at or below 25°C (77°F) with excursions permitted to 40°C (104°F)
Storage:
Store at or below 25°C (77°F) with excursions permitted to 40°C (104°F)
You May Also Like
Customer Reviews